Detalles de la búsqueda
1.
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens.
Breast Cancer Res Treat
; 188(2): 449-458, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909203
2.
Surgical treatment of gastric cancer liver metastases: Systematic review and meta-analysis of long-term outcomes and prognostic factors.
Crit Rev Oncol Hematol
; 163: 103313, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34044098
3.
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE.
J Bone Oncol
; 26: 100341, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33425672
4.
Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study.
Ther Adv Med Oncol
; 12: 1758835920968725, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33193831
5.
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial.
J Clin Oncol
; 38(27): 3138-3149, 2020 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32678716
6.
Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study.
Tumori
; 105(3): 243-252, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30857495
7.
Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.
PLoS One
; 13(7): e0199642, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29979712
8.
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
Oncology
; 71(5-6): 341-6, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17855795
9.
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).
Sci Rep
; 5: 16331, 2015 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26573509
10.
Granulocyte colony-stimulating factors used in clinical practice: PoloNord Registry-Based Cohort Italian Study.
Tumori
; 100(5): 491-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25343541
11.
Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutations.
Clin Lung Cancer
; 12(2): 138-41, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21550561
12.
D-dimer before chemotherapy might predict venous thromboembolism.
Blood Coagul Fibrinolysis
; 20(3): 170-5, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19276795
13.
The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.
Blood Coagul Fibrinolysis
; 20(1): 35-40, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20523163
Resultados
1 -
13
de 13
1
Próxima >
>>